Construction and use of mouse model for efficiently obtaining tumor antigen-specific b cells

WO2025020173A1PCT designated stage expired Publication Date: 2025-01-30BEIJING INST FOR STEM CELL & REGENERATIVE MEDICINE
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2023/109595
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-07-27
Publication Date
2025-01-30

Smart Images

  • Figure CN2023109595_30012025_PF_FP_ABST
    Figure CN2023109595_30012025_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to the field of tumor immunology, and particularly relates to a gene editing-based animal model, for efficiently and rapidly screening for tumor antigen-specific B cells, obtaining antibody information, and providing a new target for clinical personalized treatment.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Human DPP4 gene knock-in mouse model and production method and use thereof

    CN109022489A

  • Cells for expressing tumor related antigen and construction method and application of cells for expressing tumor related antigen

    CN111320701A

  • Construction method of mouse model for conditional knockout of DHX9 gene in B cell

    CN116083482A

  • Construction and application of mouse model for accurately distinguishing functional hematopoietic stem cells

    CN116355960A

  • G-protein coupled receptor 30 (GPR30) knockout mice as a model for cardiovascular diseases

    WO2010006703A1